Ira Musmuca

Combining 3-D Quantitative Structure−Activity Relationship with Ligand Based and Structure Based Alignment Procedures for<i>in Silico</i>Screening of New Hepatitis C Virus NS5B Polymerase Inhibitors

Ira Musmuca, Antonia Caroli, Antonello Mai et al. · Journal of Chemical Information and Modeling · 2010 · 56 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3<i>H</i>)-ones, a Series of Anti-HIV-1 Agents of the Dihydro-alkoxy-benzyl-oxopyrimidine Family with Peculiar Structure−Activity Relationship Profile

Maxim B. Nawrozkij, Dante Rotili, Domenico Tarantino et al. · Journal of Medicinal Chemistry · 2008 · 52 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

2-(Alkyl/Aryl)Amino-6-Benzylpyrimidin-4(3<i>H</i>)-ones as Inhibitors of Wild-Type and Mutant HIV-1: Enantioselectivity Studies

Dante Rotili, Alberta Samuele, Domenico Tarantino et al. · Journal of Medicinal Chemistry · 2012 · 31 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Inhibition of hepatitis C virus NS5B polymerase by S-trityl-l-cysteine derivatives

Daniel Brian Nichols, Guy Fournet, K.R. Gurukumar et al. · European Journal of Medicinal Chemistry · 2012 · 20 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +12

Comprehensive model of wild-type and mutant HIV-1 reverse transciptases

Flavio Ballante, Ira Musmuca, Garland R. Marshall et al. · Journal of Computer-Aided Molecular Design · 2012 · 16 citations

Life Sciences, Genetics, Molecular Biology +6